Establishment of an HLA-typed cohort of 1000 healthy blood donors and use of a dendritic cell priming assay to prime naive T cells to structurally divergent drugs (2014)
Attributed to:
Centre for Drug Safety Science (CDSS)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/2045-7022-4-s3-p112
Publication URI: http://dx.doi.org/10.1186/2045-7022-4-s3-p112
Type: Journal Article/Review
Parent Publication: Clinical and Translational Allergy
Issue: S3